| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
The real-world study will assess the clinical and operational impact of portable MRI across diverse patient types in ED settings.
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance imaging (MRI) system for the brain—the Swoop® system—today announced the enrollment of the first patients in the PRIME (Portable Rapid Imaging for Medical Emergencies) study. This study aims to evaluate the potential of AI-powered portable MRI technology to transform triage in the emergency department (ED) setting.
The PRIME study at Yale School of Medicine builds on the ACTION PMR study, which demonstrated the utility of AI-powered portable MRI in the diagnosis and management of stroke patients in emergency department settings. Expanding the scope of patients studied, the PRIME study will include a broad and diverse set of patients presenting in an emergency department and assess the technology's potential effectiveness and efficiency as a triage tool for a wide range of brain-related emergency medical conditions. Unlike ACTION PMR, the PRIME study is being conducted using the recently released next-generation Swoop® system powered by Optive AI™ software. PRIME will be one of the first studies using the new software's advanced image quality that provides sharper anatomical detail, thus potentially enabling greater pathology detection.
Hyperfine's portable MRI technology has established its value in healthcare institutions, providing high-quality brain imaging at the bedside for critically ill adult and pediatric patients. Timely access to MRI in emergency department settings is still a challenge for many hospitals. Prolonged patient boarding in EDs has been cited as the top priority for hospital leaders, as evidenced in the December 2024 article in Becker's Hospital Review1. By removing the traditional barriers associated with access to conventional MRI scanners—such as wait times, shortage of dedicated MRI technologists, cost, and immobility—portable MR imaging enables faster, more efficient decision-making in emergency department settings.
The PRIME study will enroll patients in a Level 1 emergency department, assessing a broad spectrum of emergency medical conditions. "By evaluating the potential of portable MRI in this real-world setting, this study aims to determine if a portable MRI system can provide diagnostic imaging capabilities that can be quickly integrated into the ED workflow to improve patient care decisions in real time," said Dr. Kevin Sheth, Professor of Neurology and Neurosurgery at the Yale School of Medicine and principal investigator for the PRIME study, who is working in close collaboration with his co-PI Dr. Adam De Havenon.
Posted In: HYPR
